TRXC News and Press, TransEnterix Inc. From 02/26/19

TransEnterix, Inc. (TRXC) Q4 2018 Earnings Conference Call February 26, 2019 08:00 ET Company Participants Mark Klausner - Investor Relations Todd Pope - President and Chief Executive Officer Joe Slattery - Executive Vice President and Chief Financial Officer Conference Call ...

VistaGen Therapeutics (NASDAQ: VTGN )  -23%  on announcing stock offering. More news on: VistaGen Therapeutics, Inc., TransEnterix, Inc., China Internet Nationwide Financial Services Inc., Stocks on the move, Read more ...

TransEnterix ( TRXC ) Q4 results : Revenues: $7.5M (+120.6%). More news on: TransEnterix, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

TransEnterix (NYSEMKT: TRXC ): Q4 Non-GAAP EPS of -$0.07 misses by $0.01 ; GAAP EPS of -$0.03 beats by $0.03 . More news on: TransEnterix, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter and full year 2018. Recent Highlights...

AMWD , ATHM , AVNS , AZO , BCC , BLD , BMO , BNS , BPMC , CBRL , CLVS , DISCA , DSX , FCN , HD , LGIH , LNG , M , MNK , NCI , NXST , RHP , RLGY , SAFM , SDRL , SERV , SFL , SJM , SRE , SSTK , TA , TLRA , TPH , TREE , TRI , TRXC , USCR , VCEL , WP , WY...

TransEnterix (NYSEMKT: TRXC ) is scheduled to announce Q4 earnings results on Tuesday, February 26th, before market open. More news on: TransEnterix, Inc., Earnings news and commentary, , Healthcare stocks news, Read more ...

Overview Apyx Medical ( APYX ) is a cosmetic surgery medical device company that has gone on quite a run over the last six months with the stock up a whopping 70% (from when the company name was Bovie Medical BVX). The hype surrounding Apyx is predicated on the potential commercialization ...

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2018 financial and operating results before the market opens on Tuesday, February 26, 2019. Todd M. Pope,President and Chief Executive Officer, and Joseph P. Slattery, Executive V...

A Highly Undervalued Company In A Hot Market For Acquisitions Creates A Rare Opportunity Stereotaxis ( STXS ) has developed an innovative magnetic robotic surgery system for repairing heart arrhythmias and other heart conditions. Extensive data shows that STXS’s robotic magnetic n...